Takeda(TAK) - 2024 Q4 - Annual Report

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 TAKEDA PHARMACEUTICAL COMPANY LIMITED (Translation of registrant's name into English) Form 20-F ☒ Form 40-F ☐ Exhibit Number Norimasa Takeda Chief Accounting Officer and Corporate Controller News Release U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission File Number: 001-38757 Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or ...